Pyrazino[2,3-f]quinoxaline, chloride, ruthenium(2+) salt (3:1) is a coordination compound that features a complex of ruthenium with a pyrazinoquinoxaline ligand. This compound typically exhibits characteristics associated with both its organic and inorganic components. The pyrazinoquinoxaline moiety contributes to its potential biological activity, often displaying properties such as antitumor or antimicrobial effects due to its heterocyclic structure. The presence of ruthenium in the +2 oxidation state suggests that the compound may exhibit interesting redox properties, making it a candidate for various catalytic applications. The chloride ions in the structure can influence solubility and stability in different solvents. Additionally, the stoichiometry of 3:1 indicates a specific ratio of the ligand to the metal center, which can affect the compound's overall geometry and electronic properties. Overall, this compound is of interest in fields such as medicinal chemistry and materials science due to its unique structural features and potential applications.

pyrazino[2,3-f]quinoxaline, chloride, ruthenium(2+) salt (3:1)

88181-59-3: Pyrazino[2,3-f]quinoxaline, chloride, ruthenium(2+) salt (3:1) is a coordination compound that features a complex of ruthenium with a pyrazinoquinoxaline ligand. This compound typically exhibits characteristics associated with both its organic and inorganic components. The pyrazinoquinoxaline moiety contributes to its potential biological activity, often displaying properties such as antitumor or antimicrobial effects due to its heterocyclic structure. The presence of ruthenium in the +2 oxidation state suggests that the compound may exhibit interesting redox properties, making it a candidate for various catalytic applications. The chloride ions in the structure can influence solubility and stability in different solvents. Additionally, the stoichiometry of 3:1 indicates a specific ratio of the ligand to the metal center, which can affect the compound's overall geometry and electronic properties. Overall, this compound is of interest in fields such as medicinal chemistry and materials science due to its unique structural features and potential applications.

CAS 88181-59-3

pyrazino[2,3-f]quinoxaline, chloride, ruthenium(2+) salt (3:1)

Ruthenium(2+),tris(pyrazino[2,3-f]quinoxaline-kN1,kN10)-, dichloride, (OC-6-11)-(9CI)

Ref: IN-DA004CMF